BRAF and neoplasm: Contradictory results from other groups have stressed that, although BRAFV600E mutation may show very high prevalence of the BRAF mutation in PTC in the population, the presence of the mutation itself was not statistically associated with a metastasis, patient age, completeness of resection, local invasion or tumor size score.